Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Cardiac Electrophysiology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Neurocardiogenic syncope: frequency and consequences of its misdiagnosis as epilepsy.Can J Neurol Sci. 2007; 34: 221-224
- The incidence of malignant vasovagal syndrome in patients with recurrent syncope.Eur Heart J. 1991; 12: 389-394
- AHA/ACCF scientific statement on the evaluation of syncope.J Am Coll Cardiol. 2006; 47: 473-484
- Indications, methodology, and classification of results of tilt table testing.Am J Cardiol. 1999; 84: 10-19
- Permanent pacing for cardioinhibitory malignant vasovagal syndrome.Br Heart J. 1994; 71: 274-281
- Clinical experience with Thera DR rate-drop response pacing algorithm in carotid sinus syndrome and vasovagal syncope. The International Rate-Drop Investigators Group.Pacing Clin Electrophysiol. 1997; 20: 832-839
- Effect of dual-chamber pacing with automatic rate-drop sensing on recurrent neurally medicated syncope.Am J Cardiol. 1998; 81: 158-162
- Permanent cardiac pacing versus medical treatment for the prevention of recurrent vasovagal syncope: a multicenter, randomized, controlled trial.Circulation. 2001; 104: 52-57
- The North American Vasovagal Pacemaker Study (VPS). A randomised trial of permanent cardiac pacing or the prevention of vasovagal syncope.J Am Coll Cardiol. 1999; 33: 16-20
- Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope; pacemaker versus no therapy – a multicoated randomised study. The Vasovagal Syncope International Study (VASIS) Investigators.Circulation. 2000; 102: 294-299
- Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial.JAMA. 2003; 289: 2224-2229
- A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The Vasovagal Syncope and Pacing Trial (SYNPACE).Eur Heart J. 2004; 25: 1741-1748
- The expectation effect and cardiac pacing for refractory vasovagal syncope.Am J Med. 2007; 120: 54-62
- Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) Group.Eur Heart J. 2006; 27: 2232-2239
- Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. International Study on Syncope of Uncertain Etiology 2 (ISSUE 2) group.Eur Heart J. 2006; 27: 1085-1092
- International Study on Syncope of Uncertain Etiology 3 (ISSUE 3): pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design.Europace. 2007; 9: 25-30
Article info
Identification
Copyright
© 2010 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
